PMS39 COST-UTILITY OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INSUFFICIENT RESPONSE OR INTOLERANCE TO ANTI-TNF THERAPY IN ITALY- A PROBABILISTIC SENSITIVITY ANALYSIS
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66808-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)66808-8/fulltext
Title :
PMS39 COST-UTILITY OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS WITH AN INSUFFICIENT RESPONSE OR INTOLERANCE TO ANTI-TNF THERAPY IN ITALY- A PROBABILISTIC SENSITIVITY ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66808-8&doi=10.1016/S1098-3015(10)66808-8
First page :
Section Title :
Open access? :
No
Section Order :
641